|Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 …|
C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Nikšić, ...
The Lancet 391 (10125), 1023-1075, 2018
|Survival of women with cancers of breast and genital organs in Europe 1999–2007: results of the EUROCARE-5 study|
M Sant, MDC Lopez, R Agresti, MJS Pérez, B Holleczek, ...
European journal of cancer 51 (15), 2191-2205, 2015
|Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors …|
V Ludovini, F Bianconi, L Pistola, R Chiari, V Minotti, R Colella, D Giuffrida, ...
Journal of thoracic oncology 6 (4), 707-715, 2011
|High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in …|
V Ludovini, G Bellezza, L Pistola, F Bianconi, L Di Carlo, A Sidoni, ...
Annals of oncology 20 (5), 842-849, 2009
|Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5|
C Lepage, R Capocaccia, M Hackl, V Lemmens, E Molina, ...
European Journal of Cancer 51 (15), 2169-2178, 2015
|Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: results from EUROCARE-5|
LA Anderson, A Tavilla, H Brenner, S Luttmann, C Navarro, AT Gavin, ...
European Journal of Cancer 51 (15), 2144-2157, 2015
|Italian cancer figures, report 2012: Cancer in children and adolescents.|
P Pisani, C Buzzoni, E Crocetti, LD Maso, R Rondelli, D Alessi, M Aricò, ...
|Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study|
A Trama, R Foschi, N Larrañaga, M Sant, R Fuentes-Raspall, D Serraino, ...
European Journal of Cancer 51 (15), 2206-2216, 2015
|Survival patterns in lung and pleural cancer in Europe 1999–2007: results from the EUROCARE-5 study|
S Francisci, P Minicozzi, D Pierannunzio, E Ardanaz, A Eberle, ...
European Journal of Cancer 51 (15), 2242-2253, 2015
|Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study|
E Crocetti, S Mallone, TE Robsahm, A Gavin, D Agius, E Ardanaz, ...
European Journal of Cancer 51 (15), 2179-2190, 2015
|Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study|
R De Angelis, P Minicozzi, M Sant, L Dal Maso, DH Brewster, ...
European Journal of Cancer 51 (15), 2254-2268, 2015
|Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study|
O Visser, E Ardanaz, L Botta, M Sant, A Tavilla, P Minicozzi, M Hackl, ...
European Journal of Cancer 51 (15), 2231-2241, 2015
|Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.|
AIRTUM Working Group
Epidemiologia e prevenzione 38 (6 Suppl 1), 1, 2014
|Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations|
V Ludovini, F Bianconi, L Pistola, V Minotti, R Chiari, R Colella, ...
Cancer chemotherapy and pharmacology 69 (5), 1289-1299, 2012
|Computational model of EGFR and IGF1R pathways in lung cancer: a systems biology approach for translational oncology|
F Bianconi, E Baldelli, V Ludovini, L Crino, A Flacco, P Valigi
Biotechnology advances 30 (1), 142-153, 2012
|Changes in cervical cancer incidence following the introduction of organized screening in Italy|
D Serraino, A Gini, M Taborelli, G Ronco, P Giorgi-Rossi, M Zappa, ...
Preventive medicine 75, 56-63, 2015
|Information technology as tools for cancer registry and regional cancer network integration|
F Bianconi, V Brunori, P Valigi, F La Rosa, F Stracci
IEEE Transactions on Systems, Man, and Cybernetics-Part A: Systems and …, 2012
|Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non–small cell lung cancer patients|
M Ragusa, J Vannucci, V Ludovini, F Bianconi, S Treggiari, FR Tofanetti, ...
American journal of clinical oncology 37 (4), 343-349, 2014
|Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis|
V Ludovini, F Bianconi, A Siggillino, D Piobbico, J Vannucci, G Metro, ...
Oncotarget 7 (21), 30561, 2016
|Linking surgical specimen length and examined lymph nodes in colorectal cancer patients|
F Stracci, F Bianconi, S Leite, A Liso, F La Rosa, V Lancellotta, ...
European Journal of Surgical Oncology (EJSO) 42 (2), 260-265, 2016